Showing results (11-20 of 30) with videos related to
Sort By:
Pageof 3
Asian Pacific Journal of Tropical Medicine|October 15, 2014
Effect of a novel oral active iron chelator: 1-(N-acetyl-6-aminohexyl)-3-hydroxy-2-methylpyridin-4-one (CM1) in iron-overloaded and non-overloaded miceNittaya Chansiw, Kanjana Pangjit, Chada Phisalaphong, et al.Pediatric Neurology|October 22, 2013
Automatically quantified diffuse excessive high signal intensity on MRI predicts cognitive development in preterm infantsNehal A Parikh, Lili He, Eliana Bonfante-Mejia, et al.NPJ Genomic Medicine|December 5, 2024
The genetic landscape of autism spectrum disorder in an ancestrally diverse cohortAshlesha Gogate, Kiran Kaur, Raida Khalil, et al.Blood Cells, Molecules & Diseases|November 16, 2012
Combined chelation therapy with deferasirox and deferoxamine in thalassemiaAshutosh Lal, John Porter, Nancy Sweeters, et al.Plos One|April 18, 2017
Xp11.22 deletions encompassing CENPVL1, CENPVL2, MAGED1 and GSPT2 as a cause of syndromic X-linked intellectual disabilityChristina Grau, Molly Starkovich, Mahshid S Azamian, et al.Haematologica|May 4, 2006
Predicting erythroid response to recombinant erythropoietin plus granulocyte colony-stimulating factor therapy following a single subcutaneous bolus in patients with myelodysplasiaDavid Bowen, Ann Hyslop, Norene Keenan, et al.British Journal of Haematology|October 3, 2006
Oxidative stress and inflammation in iron-overloaded patients with beta-thalassaemia or sickle cell diseasePatrick B Walter, Ellen B Fung, David W Killilea, et al.Journal of Cardiovascular Magnetic Resonance : Official Journal of the Society for Cardiovascular Magnetic Resonance|May 22, 2013
Treatment of heart failure in adults with thalassemia major: response in patients randomised to deferoxamine with or without deferiproneJohn B Porter, John Wood, Nancy Olivieri, et al.NPJ Genomic Medicine|February 22, 2022
Analysis of recent shared ancestry in a familial cohort identifies coding and noncoding autism spectrum disorder variantsIslam Oguz Tuncay, Nancy L Parmalee, Raida Khalil, et al.Haematologica|May 13, 2008
Inflammation and oxidant-stress in beta-thalassemia patients treated with iron chelators deferasirox (ICL670) or deferoxamine: an ancillary study of the Novartis CICL670A0107 trialPatrick B Walter, Eric A Macklin, John Porter, et al.Pageof 3